|
TFAP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.919600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.092000E-02 |
| Normal-vs-Stage2 |
3.308200E-01 |
| Normal-vs-Stage3 |
3.187900E-02 |
| Normal-vs-Stage4 |
3.424700E-03 |
| Stage1-vs-Stage2 |
6.628200E-01 |
| Stage1-vs-Stage3 |
2.829600E-01 |
| Stage1-vs-Stage4 |
1.191830E-02 |
| Stage2-vs-Stage3 |
2.858600E-01 |
| Stage2-vs-Stage4 |
3.556100E-02 |
| Stage3-vs-Stage4 |
1.589580E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.926300E-02 |
| Normal-vs-AfricanAmerican |
2.145600E-01 |
| Normal-vs-Asian |
1.958070E-02 |
| Caucasian-vs-AfricanAmerican |
6.714000E-01 |
| Caucasian-vs-Asian |
3.048400E-01 |
| AfricanAmerican-vs-Asian |
9.438000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.221600E-03 |
| Normal-vs-Female |
1.000850E-01 |
| Male-vs-Female |
5.523500E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.340410E-01 |
| Normal-vs-Age(41-60Yrs) |
1.762350E-02 |
| Normal-vs-Age(61-80Yrs) |
2.047700E-02 |
| Normal-vs-Age(81-100Yrs) |
8.406600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.339200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.335570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.173600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.658200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.669200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.395600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.548200E-01 |
| Classical-VS-Follicular |
9.577600E-02 |
| Classical-VS-Other |
2.752400E-01 |
| Classical-VS-Normal |
1.943700E-02 |
| Tall-VS-Follicular |
4.317800E-02 |
| Tall-VS-Other |
4.519600E-01 |
| Tall-VS-Normal |
1.526330E-02 |
| Follicular-VS-Other |
1.755630E-01 |
| Follicular-VS-Normal |
3.689800E-01 |
| Other-VS-Normal |
1.241360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.096200E-02 |
| Normal-vs-N1 |
1.987190E-01 |
| N0-vs-N1 |
7.900200E-01 |
|
|
